These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 28361857
1. Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics. Chekhun VF, Lukianova NY, Borikun TV, Zadvorny TV, Mokhir A. Exp Oncol; 2017 Mar; 39(1):25-29. PubMed ID: 28361857 [Abstract] [Full Text] [Related]
2. Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics. Chekhun VF, Borikun TV, Lukianova NY. Exp Oncol; 2016 Mar; 38(1):26-30. PubMed ID: 27031715 [Abstract] [Full Text] [Related]
5. Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs. Yalovenko TM, Todor IM, Lukianova NY, Chekhun VF. Exp Oncol; 2016 Jun; 38(2):84-8. PubMed ID: 27356575 [Abstract] [Full Text] [Related]
6. Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells. Chekhun VF, Zalutskii IV, Naleskina LA, Lukianova NY, Yalovenko TM, Borikun TV, Sobchenko SO, Semak IV, Lukashevich VS. Exp Oncol; 2015 Sep; 37(3):181-6. PubMed ID: 26422101 [Abstract] [Full Text] [Related]
7. Cytoprotective effects of ferritin on doxorubicin-induced breast cancer cell death. Buranrat B, Connor JR. Oncol Rep; 2015 Nov; 34(5):2790-6. PubMed ID: 26352101 [Abstract] [Full Text] [Related]
9. Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene. Yahya SMM, Nabih HK, Elsayed GH, Mohamed SIA, Elfiky AM, Salem SM. Breast Cancer Res Treat; 2024 Feb; 204(1):133-149. PubMed ID: 38057687 [Abstract] [Full Text] [Related]
10. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss. Zhong T, Xu F, Xu J, Liu L, Chen Y. Biomed Pharmacother; 2015 Feb; 69():317-25. PubMed ID: 25661377 [Abstract] [Full Text] [Related]
11. miRNA-34a is associated with docetaxel resistance in human breast cancer cells. Kastl L, Brown I, Schofield AC. Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894 [Abstract] [Full Text] [Related]
12. miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1. Yang X, Hu Q, Hu LX, Lin XR, Liu JQ, Lin X, Dinglin XX, Zeng JY, Hu H, Luo ML, Yao HR. Discov Med; 2017 Sep; 24(131):75-85. PubMed ID: 28972876 [Abstract] [Full Text] [Related]
13. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells. Zhong S, Li W, Chen Z, Xu J, Zhao J. Gene; 2013 Nov 15; 531(1):8-14. PubMed ID: 23994196 [Abstract] [Full Text] [Related]
16. Association of CD44+CD24-/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer. Chekhun VF, Lukianova NY, Chekhun SV, Bezdieniezhnykh NO, Zadvorniy TV, Borikun TV, Polishchuk LZ, Klyusov OМ. Exp Oncol; 2017 Sep 15; 39(3):203-211. PubMed ID: 28967645 [Abstract] [Full Text] [Related]
19. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines. Zhuo L, Liu J, Wang B, Gao M, Huang A. Oncol Rep; 2013 Feb 15; 29(2):555-62. PubMed ID: 23229111 [Abstract] [Full Text] [Related]